does glp-1 show up on drug test medications get at the heart of addiction: study – WashU Medicine GLP-1 medications like Ozempic, Wegovy

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl peptidase-4 inhibitors, according to findings scheduled for presentation at ASCO Annual Meeting

Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes

Although limited, the evidence suggests that combined therapy has an enhanced effect in reducing cardiovascular events in selected populations and positively impacting important surrogate kidney disease markers

Brussels, Belgium

Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of diabetic nephropathy in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study

People are actually losing weight and I can see the visible difference, she said